ICON Reports Full-Year 2009 EPS Growth of 18% and Announces Revenue and EPS Guidance for 2010

DUBLIN--(BUSINESS WIRE)--ICON (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter ended December 31, 2009.

Back to news